Step aside, psilocybin: A new shroom is in town. According to a new study by researchers at the University of California (UC) San Diego’s Herbert Wertheim School of Public Health and Human Longevity Science, the use of Amanita muscaria mushrooms has surged in the U.S. based upon Google searches. The research indicates Google searches increased… Keep Reading
Recently, researchers Christopher P. Holstege and Rita Farah unveiled the results of their study on the increase in poison center calls for mushroom consumption. In “Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade,” the researchers explored the rising trend of accidental exposure to psilocybin between January 1, 2024-December 31, 2022. Holstege… Keep Reading
Cannabis does not cause “next-day impairment” researchers found in a new study published last week in the journal Psychopharmacology. Researchers found little evidence to suggest that THC can impact a person’s performance the next day, though any experienced smoker could tell you the same. Researchers observed 20 adults with physician-diagnosed insomnia who consumed cannabis irregularly,… Keep Reading
A newly published study from researchers at New York University found that individuals dealing with a stutter derived some benefit from substances such as psilocybin, the psychoactive compound in “magic mushrooms,” and LSD. “Given the positive effects of psychedelics on conditions like anxiety and PTSD, which share symptoms with stuttering, we think that investigating the… Keep Reading
In a study that was originally published late last year, researchers unveiled the risks for former cocaine users who may relapse by taking methylphenidate. Methylphenidate is used as a treatment for attention-deficit hyperactivity disorder (ADHD), and is often recognized through brands such as Aptensio XR, Concerta/Concerta XR-ODT, Jornay PM, and most commonly, Ritalin. As a… Keep Reading
Researchers from Romania published the results of a study in the International Journal of Molecular Sciences exploring and analyzing the effects of various phytocannabinoids and terpenes working together. Phytocannabinoids include any naturally occurring cannabinoid found in the plant, from the more commonly known THC, and CBD to less known CBC, CBG, CBN, and more. Researchers… Keep Reading
Hop latent viroid (HLVd) is one of the most devastating things ever to hit cannabis, with researchers estimating it could be costing the industry up to $4 billion per year in financial loss. But are the streets safer than the recreational mega-farms that were decimated in the transition to legalization? We reached out to some… Keep Reading
By Paul Derienzo Top-level federal researchers and bureaucrats, as well as grass-roots activists in drug-ravaged urban communities, have discovered ibogaine, the controversial drug that advocates tout as an “addiction interrupter” and one scientist calls a “probe into the inner workings of the human brain.” Derived from iboga, an hallucinogenic plant of the West African rainforests,… Keep Reading
The more cannabis becomes accepted in the U.S., the more frustrating it becomes that cannabis researchers are barred by Schedule I status and cannot freely research, as well as that communities of color remain more at-risk for incarceration. The new PBS and NOVA documentary The Cannabis Question tackles both problems in one, succinct film. The… Keep Reading
